Human coronavirus HKU1 is an enveloped positive‑sense RNA virus in the subgenus Embecovirus that infects humans and causes primarily respiratory illnesses.
Explanation
Human coronavirus HKU1 (HCoV‑HKU1) was first identified in 2005 in a pneumonia patient in Hong Kong. This virus belongs to the genus Betacoronavirus, subgenus Embecovirus, within the family Coronaviridae. Its genome is a positive‑sense single‑stranded RNA of about 30 kilobases and encodes the spike, envelope, membrane and nucleocapsid proteins. Phylogenetic analyses place HCoV‑HKU1 close to murine hepatitis virus and bovine coronavirus, suggesting a zoonotic origin and several recombination events. Four lineages have been described, reflecting ongoing genetic diversification. HCoV‑HKU1 is one of four endemic human coronaviruses, along with HCoV‑229E, HCoV‑NL63 and HCoV‑OC43, that account for a significant proportion of respiratory tract infections worldwide. Infections are most common in winter and early spring. Most cases present as upper respiratory illness with cough, rhinorrhea, fever and sore throat, but infants, older adults and patients with underlying conditions can develop lower respiratory disease such as bronchitis or pneumonia. Serological surveys show that antibodies to HCoV‑HKU1 are widespread in adult populations, yet immunity appears to wane within a year, allowing reinfection throughout life. There is no specific antiviral treatment; management is supportive, and research into this virus informs understanding of coronavirus diversity and evolution.
Clinical Significance and Notable Findings
HCoV‑HKU1 spreads mainly through respiratory droplets and close contact. Documented outbreaks in hospital wards and long‑term care facilities demonstrate its ability to cause nosocomial transmission. Detection rates among patients with acute respiratory illness range from 1 % to 10 % in surveillance studies, and coinfection with other respiratory viruses is common. While most infections are mild, severe pneumonia requiring intensive care has been reported in immunocompromised individuals. Studies on human airway epithelial cultures show that the virus replicates efficiently in ciliated epithelial cells but does not replicate well in murine hosts without adaptation. Continued genomic sequencing has uncovered multiple genotypes with regional variation, underscoring the need for ongoing monitoring. Proper hand hygiene and isolation of symptomatic individuals remain the main preventive measures, as no vaccine is available. HCoV‑HKU1 is a widespread betacoronavirus associated with mild respiratory illness. Its discovery highlights the breadth of coronaviruses that circulate in humans. Ongoing surveillance and research are essential to track its evolution and assess its potential public health impact. Related Terms: HCoV‑OC43, HCoV‑229E, HCoV‑NL63, SARS‑CoV‑2, MERS‑CoV